Category: BREAST CANCER MARKER | Code: A5101
HER2 CISH, dual color
Function
HER-2/NEU expression is commonly examined in breast carcinoma. Women who have tumors that overexpress HER-2/NEU are more likely to be responsive to monoclonal antibody therapy.
| Test Schedule | Estimated Test Result | Container | Substance | Stability |
|---|---|---|---|---|
| Monday - Friday | 7 days | - | FFPE Block | Room temperature |
Condition
The block must contain tumor cells
Method
Immunocytochemical Assay
